257 related articles for article (PubMed ID: 7684684)
21. Class I MHC-peptide interactions: structural requirements and functional implications.
Grey HM; Ruppert J; Vitiello A; Sidney J; Kast WM; Kubo RT; Sette A
Cancer Surv; 1995; 22():37-49. PubMed ID: 7536628
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of peptides associated with class II MHC molecules, HLA-DR3: implication for the prediction of peptides useful for vaccines].
Georges B; Gras-Masse H; Maes P; Capron A; Tartar A; Auriault C
C R Acad Sci III; 1996 Dec; 319(12):1119-25. PubMed ID: 9091183
[TBL] [Abstract][Full Text] [Related]
23. Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2Ld and is recognized by cytotoxic T lymphocytes against mouse tumor P815.
Van den Eynde B; Mazarguil H; Lethé B; Laval F; Gairin JE
Eur J Immunol; 1994 Nov; 24(11):2740-5. PubMed ID: 7525302
[TBL] [Abstract][Full Text] [Related]
24. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
[TBL] [Abstract][Full Text] [Related]
25. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
Sutton J; Rowland-Jones S; Rosenberg W; Nixon D; Gotch F; Gao XM; Murray N; Spoonas A; Driscoll P; Smith M
Eur J Immunol; 1993 Feb; 23(2):447-53. PubMed ID: 7679646
[TBL] [Abstract][Full Text] [Related]
26. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
27. Structural principles that govern the peptide-binding motifs of class I MHC molecules.
Zhang C; Anderson A; DeLisi C
J Mol Biol; 1998 Sep; 281(5):929-47. PubMed ID: 9719645
[TBL] [Abstract][Full Text] [Related]
28. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
Shirai M; Pendleton CD; Berzofsky JA
J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
[TBL] [Abstract][Full Text] [Related]
29. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.
Sette A; Sidney J; Oseroff C; del Guercio MF; Southwood S; Arrhenius T; Powell MF; Colón SM; Gaeta FC; Grey HM
J Immunol; 1993 Sep; 151(6):3163-70. PubMed ID: 7690794
[TBL] [Abstract][Full Text] [Related]
30. Modification of peptide interaction with MHC creates TCR partial agonists.
Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
[TBL] [Abstract][Full Text] [Related]
31. Major histocompatibility complex class I allele-specific peptide libraries: identification of peptides that mimic an H-Y T cell epitope.
Gavin MA; Dere B; Grandea AG; Hogquist KA; Bevan MJ
Eur J Immunol; 1994 Sep; 24(9):2124-33. PubMed ID: 7522161
[TBL] [Abstract][Full Text] [Related]
32. T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein19-31.
Wu S; Gorski J; Eckels DD; Newton-Nash DK
J Immunol; 1996 May; 156(10):3815-20. PubMed ID: 8621918
[TBL] [Abstract][Full Text] [Related]
33. Permissive recognition of a mycobacterial T-cell epitope: localization of overlapping epitope core sequences recognized in association with multiple major histocompatibility complex class II I-A molecules.
Harris DP; Vordermeier HM; Arya A; Moreno C; Ivanyi J
Immunology; 1995 Apr; 84(4):555-61. PubMed ID: 7790029
[TBL] [Abstract][Full Text] [Related]
34. The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D.
Mata M; Travers PJ; Liu Q; Frankel FR; Paterson Y
J Immunol; 1998 Sep; 161(6):2985-93. PubMed ID: 9743362
[TBL] [Abstract][Full Text] [Related]
35. Peptides of 23 residues or greater are required to stimulate a high affinity class II-restricted T cell response.
Srinivasan M; Domanico SZ; Kaumaya PT; Pierce SK
Eur J Immunol; 1993 May; 23(5):1011-6. PubMed ID: 8386663
[TBL] [Abstract][Full Text] [Related]
36. Comparison of class I- and II-restricted T cell recognition of the identical peptide.
Perkins DL; Berriz G; Wang YS; Smith JA; Gefter ML
Eur J Immunol; 1991 Nov; 21(11):2781-9. PubMed ID: 1718759
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
Jones MA; Hislop AD; Snaith JS
Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
[TBL] [Abstract][Full Text] [Related]
39. Structural complexity of antigenic determinants for class I MHC-restricted, hapten-specific T cells. Two qualitatively differing types of H-2Kb-restricted TNP epitopes.
Martin S; von Bonin A; Fessler C; Pflugfelder U; Weltzien HU
J Immunol; 1993 Jul; 151(2):678-87. PubMed ID: 8335903
[TBL] [Abstract][Full Text] [Related]
40. Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs.
Jameson SC; Bevan MJ
Eur J Immunol; 1992 Oct; 22(10):2663-7. PubMed ID: 1396971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
